A fate worse than death: apoptosis as an oncogenic process

Apoptotic cell death is widely considered a positive process that both prevents and treats cancer. Although undoubtedly having a beneficial role, paradoxically, apoptosis can also cause unwanted effects that may even promote cancer. In this Opinion article we highlight some of the ways by which apoptosis can exert oncogenic functions. We argue that fully understanding this dark side will be required to optimally engage apoptosis, thereby maximizing tumour cell kill while minimizing unwanted pro-tumorigenic effects.

[1]  O. Bairey,et al.  Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  M. Maiuri,et al.  BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy , 2015, Autophagy.

[3]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[4]  D. Vaux,et al.  Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak , 2014, Proceedings of the National Academy of Sciences.

[5]  S. Nagata,et al.  [Apoptosis and autoimmune diseases]. , 1993, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[6]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[7]  Christine Feig,et al.  CD95/Fas promotes tumour growth , 2010, Nature.

[8]  L. Liu,et al.  Nucleolytic Cleavage of the Mixed Lineage Leukemia Breakpoint Cluster Region during Apoptosis* , 2001, The Journal of Biological Chemistry.

[9]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[10]  D. Lauffenburger,et al.  Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. , 2008, Molecular cell.

[11]  J. Martinou,et al.  Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. , 2001, Molecular cell.

[12]  A. Strasser,et al.  Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis , 2009, Cell Death and Differentiation.

[13]  A. Mills,et al.  Getting around lethality with inducible Cre-mediated excision. , 2002, Seminars in cell & developmental biology.

[14]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[15]  Michael T. Certo,et al.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. , 2007, The Journal of clinical investigation.

[16]  C. Osborne,et al.  bcl‐2 and apoptosis in lymph node positive breast carcinoma , 1998, Cancer.

[17]  J. Martinez-Climent,et al.  Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma. , 2014, Blood.

[18]  S. Lowe,et al.  Genetic analysis of chemoresistance in primary murine lymphomas , 2000, Nature Medicine.

[19]  S. Pai,et al.  Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue , 2001, Cancer.

[20]  A. Letai,et al.  Diagnosing and exploiting cancer's addiction to blocks in apoptosis , 2008, Nature Reviews Cancer.

[21]  R. Weissleder,et al.  In vivo imaging of drug-induced mitochondrial outer membrane permeabilization at single-cell resolution. , 2012, Cancer research.

[22]  G. Barber,et al.  Diverse roles of STING-dependent signaling on the development of cancer , 2015, Oncogene.

[23]  J. D. Jong,et al.  Number of apoptotic cells as a prognostic marker in invasive breast cancer , 2000, British Journal of Cancer.

[24]  G. Krumschnabel,et al.  Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. , 2010, Genes & development.

[25]  J. Prehn,et al.  Central roles of apoptotic proteins in mitochondrial function , 2013, Oncogene.

[26]  R. Medema,et al.  Intravital FRET Imaging of Tumor Cell Viability and Mitosis during Chemotherapy , 2013, PloS one.

[27]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[28]  B. Hyman,et al.  Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology , 2012, Nature Reviews Neuroscience.

[29]  A. Hall,et al.  Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. , 1999, Blood.

[30]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[31]  R. Medzhitov,et al.  p53-mediated hematopoietic stem and progenitor cell competition. , 2010, Cell stem cell.

[32]  Erik Sahai,et al.  Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity , 2015, Cell.

[33]  M. Diaz,et al.  Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division. , 2003, Cancer research.

[34]  Jun R Huh,et al.  Compensatory Proliferation Induced by Cell Death in the Drosophila Wing Disc Requires Activity of the Apical Cell Death Caspase Dronc in a Nonapoptotic Role , 2004, Current Biology.

[35]  R. Larson,et al.  Therapy-related myeloid leukemia. , 2008, Seminars in oncology.

[36]  I. Ellis,et al.  Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: A tissue microarray study of 460 patients , 2005, World journal of surgical oncology.

[37]  Markus Rehm,et al.  Real-time single cell analysis of Smac/DIABLO release during apoptosis , 2003, The Journal of cell biology.

[38]  Matthew E. Ritchie,et al.  Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production , 2014, Cell.

[39]  C. Gregory,et al.  Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues , 2011, The Journal of pathology.

[40]  Karen Cichowski,et al.  Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy , 2015, Cell.

[41]  G. Evan,et al.  Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms. , 2006, Cancer cell.

[42]  M. Peter,et al.  Death induced by CD95 or CD95 ligand elimination. , 2014, Cell reports.

[43]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[44]  M. Linhoff,et al.  Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis , 2004, The Journal of cell biology.

[45]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[46]  E. Warlick Epidemiology of myelodysplastic syndromes: many questions remain , 2011, Leukemia & lymphoma.

[47]  M. Smyth,et al.  Immune surveillance of tumors. , 2007, The Journal of clinical investigation.

[48]  F. Roviello,et al.  Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer , 2006, Breast Cancer Research and Treatment.

[49]  G. Atsumi,et al.  Fas-induced Arachidonic Acid Release Is Mediated by Ca2+-independent Phospholipase A2 but Not Cytosolic Phospholipase A2, Which Undergoes Proteolytic Inactivation* , 1998, The Journal of Biological Chemistry.

[50]  D. Green,et al.  Means to an end : apoptosis and other cell death mechanisms , 2011 .

[51]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[52]  S. Fulda,et al.  Targeting IAP proteins for therapeutic intervention in cancer , 2012, Nature Reviews Drug Discovery.

[53]  Takamitsu A Kato,et al.  Caspase-3 promotes genetic instability and carcinogenesis. , 2015, Molecular cell.

[54]  James A. Wells,et al.  Small-Molecule Activators of a Proenzyme , 2009, Science.

[55]  A. Kraft,et al.  The BH3 mimetic ABT-737 induces cancer cell senescence. , 2011, Cancer research.

[56]  Flore Kruiswijk,et al.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.

[57]  T. Kipps,et al.  Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. , 2016, The New England journal of medicine.

[58]  M. Peter,et al.  The role of CD95 and CD95 ligand in cancer , 2015, Cell Death and Differentiation.

[59]  Hyung Don Ryoo,et al.  Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. , 2004, Developmental cell.

[60]  H. Wajant,et al.  Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation , 2010, Cell Death and Differentiation.

[61]  M. Redondo,et al.  The role and prognostic value of apoptosis in colorectal carcinoma , 2013, BMC Clinical Pathology.

[62]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[63]  Michael T. Lotze,et al.  Inflammation and necrosis promote tumour growth , 2004, Nature Reviews Immunology.

[64]  L. Moretti,et al.  M867, a Novel Selective Inhibitor of Caspase-3 Enhances Cell Death and Extends Tumor Growth Delay in Irradiated Lung Cancer Models , 2008, PloS one.

[65]  J. Spychała Tumor-promoting functions of adenosine. , 2000, Pharmacology & therapeutics.

[66]  S. Tait,et al.  Mitochondrial apoptosis: killing cancer using the enemy within , 2015, British Journal of Cancer.

[67]  G. Ying,et al.  Visualization of caspase-3-like activity in cells using a genetically encoded fluorescent biosensor activated by protein cleavage , 2013, Nature Communications.

[68]  Karen Blyth,et al.  Limited Mitochondrial Permeabilization Causes DNA Damage and Genomic Instability in the Absence of Cell Death , 2015, Molecular cell.

[69]  G. Barber,et al.  Inflammation-driven carcinogenesis is mediated through STING , 2014, Nature Communications.

[70]  C. Berens,et al.  UVB-irradiated apoptotic cells induce accelerated growth of co-implanted viable tumor cells in immune competent mice , 2013, Autoimmunity.

[71]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[72]  Xiaomei Ma Epidemiology of myelodysplastic syndromes. , 2012, The American journal of medicine.

[73]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[74]  Dana M. Brantley-Sieders,et al.  Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution. , 2014, The Journal of clinical investigation.

[75]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[76]  Fang Li,et al.  Apoptotic Cells Activate the “Phoenix Rising” Pathway to Promote Wound Healing and Tissue Regeneration , 2010, Science Signaling.

[77]  S. Meterissian,et al.  Bcl-2 Is a Useful Prognostic Marker in Dukes’ B Colon Cancer , 2001, Annals of Surgical Oncology.

[78]  A. Wyllie The biology of cell death in tumours. , 1985, Anticancer research.

[79]  H. Steller,et al.  Programmed Cell Death in Animal Development and Disease , 2011, Cell.

[80]  A. Strasser,et al.  PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia , 2016, Cell Death and Differentiation.

[81]  A. Jimeno,et al.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy , 2011, Nature Medicine.

[82]  Jacco van Rheenen,et al.  Imaging hallmarks of cancer in living mice , 2014, Nature Reviews Cancer.

[83]  D. Hume,et al.  Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma , 2015, Current Biology.

[84]  D. Colin,et al.  Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins , 2015, Open Biology.

[85]  J. Werner,et al.  Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. , 2015, Cancer cell.

[86]  M. Rehm,et al.  Real Time Analysis of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Cycloheximide-induced Caspase Activities during Apoptosis Initiation* , 2008, Journal of Biological Chemistry.

[87]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[88]  Mark A. Hall,et al.  Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis , 2008, Molecular and Cellular Biology.

[89]  G. Morata,et al.  Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila , 2004, Development.

[90]  S. Tait,et al.  Multiple functions of BCL-2 family proteins. , 2013, Cold Spring Harbor perspectives in biology.

[91]  M. Peter,et al.  The role of CD95 and CD95 ligand in cancer , 2015, Cell Death and Differentiation.

[92]  Y. Matsuzaki,et al.  Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[93]  G. Evan,et al.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.

[94]  G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.

[95]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[96]  S. Nagata Apoptosis and autoimmune diseases , 2010, Annals of the New York Academy of Sciences.

[97]  Baocun Sun,et al.  Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[98]  Mark P. Mattson,et al.  Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.

[99]  S. Korsmeyer,et al.  Antiapoptotic BCL-2 is required for maintenance of a model leukemia. , 2004, Cancer cell.

[100]  Laura H. Tang,et al.  Bcl-xL promotes metastasis independent of its anti-apoptotic activity , 2016, Nature Communications.

[101]  F M Blows,et al.  BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received , 2010, British Journal of Cancer.

[102]  M. Manns,et al.  The BH3‐only protein BID impairs the p38‐mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice , 2015, Hepatology.

[103]  D. Green,et al.  Mito-priming as a method to engineer Bcl-2 addiction , 2016, Nature Communications.

[104]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[105]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[106]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[107]  L. Tanoue,et al.  High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology , 2010, BMC Cancer.

[108]  Y. Xiong,et al.  The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells , 2014, Science Signaling.

[109]  D. Green,et al.  Resistance to caspase-independent cell death requires persistence of intact mitochondria. , 2010, Developmental cell.

[110]  R. Wood‐Baker,et al.  BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[111]  Chao-Po Lin,et al.  Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia. , 2006, Cancer research.

[112]  S. Mañes,et al.  CX3CL1 at the crossroad of EGF signals , 2013, Oncoimmunology.

[113]  D. Green,et al.  Die another way – non-apoptotic mechanisms of cell death , 2014, Journal of Cell Science.

[114]  Xiao-Ming Yin,et al.  Deletion of Bid impedes cell proliferation and hepatic carcinogenesis. , 2005, The American journal of pathology.

[115]  T. Mitchison,et al.  Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction , 2012, Molecular biology of the cell.

[116]  M. Peter,et al.  CD95 and CD95L promote and protect cancer stem cells , 2014, Nature Communications.

[117]  Jian Yu,et al.  PUMA–mediated apoptosis drives chemical hepatocarcinogenesis in mice , 2011, Hepatology.

[118]  Jochen H M Prehn,et al.  Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.

[119]  R. Bejar,et al.  Recent developments in myelodysplastic syndromes. , 2014, Blood.

[120]  G. Gillet,et al.  Non-apoptotic roles of Bcl-2 family: the calcium connection. , 2013, Biochimica et biophysica acta.

[121]  A. Strasser,et al.  Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. , 2010, Genes & development.

[122]  Andreas Villunger,et al.  p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa , 2003, Science.

[123]  Erinna F. Lee,et al.  Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53 , 2014, Genes & development.

[124]  L. Galluzzi,et al.  Mitochondria as therapeutic targets for cancer chemotherapy , 2006, Oncogene.

[125]  D. Gao,et al.  Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer , 2013, Breast Cancer Research and Treatment.

[126]  T. Taniguchi,et al.  Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA , 2014, Cell.

[127]  C. Knudson,et al.  Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability , 2003, Cell Death and Differentiation.

[128]  R. Pierce,et al.  Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. , 2002, The American journal of pathology.

[129]  D. Green,et al.  A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.

[130]  M. Rehm,et al.  Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation , 2010, Journal of Cell Science.

[131]  H. Ford,et al.  On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics , 2013, Oncogene.

[132]  J. Martinou,et al.  TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis , 2012, Apoptosis.

[133]  M. Kalmanti,et al.  Enhanced levels of the apoptotic BAX/BCL-2 ratio in children with acute lymphoblastic leukemia and high-risk features , 2013, Genetics and molecular biology.

[134]  C. Watson,et al.  The complexity of the relationships between age at first birth and breast cancer incidence curves implicate pregnancy in cancer initiation as well as promotion of existing lesions. Preface. , 2009, Journal of mammary gland biology and neoplasia.

[135]  J. Xiang,et al.  BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[136]  T. Chua,et al.  Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma? , 2013, American journal of cancer research.

[137]  Hui Sun,et al.  Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition , 2015, Molecular medicine reports.

[138]  L. Révész Genetic Studies of the Relationship of Tumour–Host Cells: Effect of Tumour Cells killed by X-rays upon the Growth of Admixed Viable Cells , 1956, Nature.

[139]  F. Gago,et al.  Prognostic value of Bcl‐2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy , 2008, Molecular oncology.

[140]  D. Hasenclever,et al.  High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML) , 2002, Leukemia.

[141]  R. Fietkau,et al.  Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner , 2015, Cell Death and Disease.

[142]  A. Marusyk,et al.  Irradiation Selects for p53-Deficient Hematopoietic Progenitors , 2010, PLoS biology.

[143]  A. Strasser,et al.  Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. , 2012, Blood.

[144]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[145]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[146]  Gerard I. Evan,et al.  The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant , 2000, Nature Cell Biology.

[147]  A. Azizzadeh Delshad,et al.  Correlation between Apoptosis and Histological Grade of Transitional Cell Carcinoma of Urinary Bladder. , 2004, Urology journal.

[148]  L. Wiesmüller,et al.  Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanism , 2015, Front. Cell Dev. Biol..

[149]  J. Blay,et al.  Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. , 2014, Cancer cell.

[150]  David L. Vaux,et al.  Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies , 2016, Nature Reviews Cancer.

[151]  Yali Dou,et al.  Hijacked in cancer: the KMT2 (MLL) family of methyltransferases , 2015, Nature Reviews Cancer.

[152]  K. Ravichandran,et al.  Phagocytosis of apoptotic cells in homeostasis , 2015, Nature Immunology.

[153]  A. Letai,et al.  Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy , 2011, Science.

[154]  J. Cleveland,et al.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. , 2003, Cancer cell.